Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-13

Clinical Trial Update: Vitamin D and Cardiovascular Events in Rheumatoid Arthritis

View source ↗

Summary

A completed clinical trial evaluating whether vitamin D supplementation reduces cardiovascular events in people with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Odense University Hospital | Conditions: Rheumatoid Arthritis, Cardiovascular Disease | Status: COMPLETED